Micro-Radiobinding Assay for Low-Abundance Protein Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional radiobinding assays require large amounts of protein targets, limiting their use for low-abundance proteins like those derived from human brain samples, particularly for neurodegenerative disease research, where sensitive and accurate methods are needed to characterize ligand binding and screen compounds effectively.
Innovation Solution
A miniaturized radiobinding assay using a microarray with localized microsamples of pathological proteins on a coated surface, allowing for the use of significantly lower protein amounts and enabling high-throughput screening, with detection by phosphor imaging and image analysis software.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If classical filter-based radiobinding assays are used, then binding parameters can be determined, but large amounts of target protein are required which limits the use for low-abundance proteins
Solution Approach 1:
The assay is divided into separate functional components: target protein immobilization on filter, radioligand incubation, washing steps, and counting. This segmentation allows optimization of each step to reduce protein requirements while maintaining measurement precision.
Solution Approach 2:
The patent transitions from solution-phase binding to surface-immobilized binding on filters. This dimensional change from 3D solution to 2D surface allows for more efficient use of target protein, enabling accurate Kd and Bmax determination with up to 100-fold less protein.
2Measurement precision
If protein concentrations are increased to achieve necessary levels for filtration, then adequate signal for binding determination is obtained, but the amount of required target protein increases substantially
Solution Approach 1:
The target protein is concentrated locally on the filter surface through immobilization, creating high local density that provides adequate signal for detection without requiring large total amounts of protein in the assay system.
3Reliability
If large volumes are used for filtration processes, then proper separation of bound and free ligand is achieved, but the assay requires substantial protein amounts limiting sensitivity for low-abundance targets
Solution Approach 1:
The binding assay is segmented into distinct steps with the filter serving as a physical separator. Bound ligand-target complexes are retained on the filter while free ligand is washed away, achieving reliable separation without requiring large volumes or substantial protein amounts.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the determination of binding affinity (Kd) and inhibitory constant (Ki) values using up to 500-fold less protein than classical assays, making it suitable for low-abundance proteins and facilitating the screening of ligand libraries with high sensitivity and accuracy.
Implementation Method 1
The radiolabeled ligand is labeled with a radioactive isotope and this allows the quantification of its bound fraction to the target. This is obtained by measuring the ligand intrinsic ionizing radioactivity with a detector containing photomultiplier devices.
Implementation Method 2
physical separation is usually accomplished by filtration, where the filter, generally made of nitrocellulose or glass fibers, retains only the bound ligand-target complex, while the free ligand passes through the filter and is removed.
Data Source
AI summary
The disclosure relates to binding assays that can measure the binding of ligands to a specific protein target in a micro-radiobinding assay. In particular, the present disclosure relates micro-radiobinding assays useful for low-abundance proteins, such as recombinant or tissue-derived proteins isolated from healthy or diseased, human donor samples.